Bladder capacity on preoperative urodynamics may impact outcomes on transobturator male slings

被引:18
|
作者
Warner, Jonathan N. [1 ]
Grimsby, Gwen M. [1 ]
Tyson, Mark D. [1 ]
Wolter, Christopher E. [1 ]
机构
[1] Mayo Clin, Dept Urol, Phoenix, AZ USA
关键词
artificial urinary sphincter (AUS); body mass index (BMI); detrusor overactivity (DO); external urethral sphincter (EUS); intrinsic sphincter deficiency (ISD); post-prostatectomy incontinence (PPI); post void residual (PVR); stress urinary incontinence (SUI); transobturator sling (TOS); urodynamics (UDS); urinary retention (UR); valsalva leak point pressure (VLPP); POSTRADICAL PROSTATECTOMY INCONTINENCE; ARTIFICIAL URINARY SPHINCTER; POSTPROSTATECTOMY INCONTINENCE; RADICAL PROSTATECTOMY; TRANSURETHRAL RESECTION; MANAGEMENT; PATHOPHYSIOLOGY; PARAMETERS; MORBIDITY; DETRUSOR;
D O I
10.1002/nau.22233
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims Stress incontinence is frequently seen after prostate surgery. We sought to evaluate preoperative urodynamic (UDS) parameters on functional outcomes after transobturator male sling placement. Methods 49 male patients with stress urinary incontinence (SUI) after radical prostatectomy or transurethral resection of the prostate underwent transobturator sling (TOS) placement from December 2008 through June 2011 (AdVance (R) and Virtue (R)). A retrospective review was performed of those patients who underwent preoperative UDS and had a minimum of 6 weeks of follow up. In total 38 patients were identified. There were 28 patients considered a success and 10 patients considered a failure. We then evaluated the preoperative UDS parameters between these two groups to identify potential adverse parameters. Results Overall success rate was 74% (28/38) with an average follow up of 3 months. Comparing the success and failure groups there was no difference between the pre-operative parameters. On pre-operative UDS, only bladder capacity was found to be significantly lower in those who failed TOS. Univariate comparisons of sling outcomes stratified by bladder capacity tertiles was performed. These values were chosen as they represented the 25th, 50th, and 75th percentiles, respectively. All patients (10/10) with bladder capacities in the top tertile experienced success with the sling, compared to only 62% and 50% of patients in the 50th and 25th tertiles, respectively; these differences were significant (Fisher's exact P-value?=?0.044). Conclusion TOS is an effective therapy for men with SUI. Bladder capacity based on pre-operative UDS may impact the success of the procedure. Neurourol. Urodynam. 31:11241127, 2012. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:1124 / 1127
页数:4
相关论文
共 39 条
  • [31] PREOPERATIVE IMPACT OF ALBUMIN TO FIBRINOGEN RATIO (AFR) ON ONCOLOGICAL OUTCOMES IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER (MIBC) TREATED WITH RADICAL CYSTECTOMY
    Claps, Francesco
    Boltri, Matteo
    Ongaro, Luca
    Migliozzi, Francesca
    Pavan, Nicola
    Rizzo, Michele
    Liguori, Giovanni
    Trombetta, Carlo
    ANTICANCER RESEARCH, 2019, 39 (03) : 1583 - 1584
  • [32] Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer
    Victor M. Schuettfort
    Benjamin Pradere
    Quoc-Dien Trinh
    David D’Andrea
    Fahad Quhal
    Hadi Mostafaei
    Ekaterina Laukhtina
    Keiichiro Mori
    Reza Sari Motlagh
    Michael Rink
    Pierre I. Karakiewicz
    Piotr Chlosta
    Jeremy Yuen-Chun Teoh
    Yair Lotan
    Douglas Scherr
    Mohammad Abufaraj
    Marco Moschini
    Shahrokh F. Shariat
    Cancer Immunology, Immunotherapy, 2022, 71 : 85 - 95
  • [33] Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer
    Schuettfort, Victor M.
    Pradere, Benjamin
    Quoc-Dien Trinh
    D'Andrea, David
    Quhal, Fahad
    Mostafaei, Hadi
    Laukhtina, Ekaterina
    Mori, Keiichiro
    Motlagh, Reza Sari
    Rink, Michael
    Karakiewicz, Pierre, I
    Chlosta, Piotr
    Teoh, Jeremy Yuen-Chun
    Lotan, Yair
    Scherr, Douglas
    Abufaraj, Mohammad
    Moschini, Marco
    Shariat, Shahrokh F.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (01) : 85 - 95
  • [34] THE IMPACT OF PREOPERATIVE CHRONIC KIDNEY DISEASE ON ONCOLOGICAL OUTCOMES AFTER TRANS-URETHRAL RESECTION OF BLADDER TUMOR IN PATIENTS WITH PRIMARY NON-MUSCLE-INVASIVE BLADDER CANCER
    Fujita, Naoki
    Momota, Masaki
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Ito, Hiroyuki
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2019, 201 (04): : E226 - E227
  • [35] IMPACT OF PREOPERATIVE CONTROLLING NUTRITIONAL STATUS (CONUT) SCORE ON PERIOPERATIVE MORBIDITY AND SURVIVAL OUTCOMES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A MULTICENTER ANALYSIS
    Claps, Francesco
    Pavan, Nicola
    Maresma, Maria Carmen Mir
    Mazzon, Giorgio
    del Grappa, Bassano
    Ramirez-Backhaus, Miguel
    Boltri, Matteo
    Soria, Francesco
    Massanova, Matteo
    D'Andrea, David
    Traunero, Fabio
    Marra, Giancarlo
    Liguori, Giovanni
    Gontero, Paolo
    Shariat, Shahrokh Francois
    Briones, Jose Rubio
    Celia, Antonio
    Trombetta, Carlo
    JOURNAL OF UROLOGY, 2020, 203 : E1278 - E1278
  • [36] Impact of Preoperative Plasma Potassium Levels on Oncological Outcomes, Major Complications, and 30-Day Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy
    Klemm, Jakob
    Shariat, Shahrokh F.
    Laukhtina, Ekaterina
    Rajwa, Pawel
    Vetterlein, Malte W.
    Schuettfort, Victor M.
    von Deimling, Markus
    Dahlem, Roland
    Fisch, Margit
    Rink, Michael
    CLINICAL GENITOURINARY CANCER, 2024, 22 (03)
  • [37] Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer
    Singla, Nirmish
    Haddad, Ahmed Q.
    Passoni, Niccolo M.
    Meissner, Matthew
    Lotan, Yair
    WORLD JOURNAL OF UROLOGY, 2017, 35 (01) : 105 - 111
  • [38] Anti-inflammatory use may not negatively impact oncologic outcomes following intravesical BCG for high-grade non-muscle-invasive bladder cancer
    Nirmish Singla
    Ahmed Q. Haddad
    Niccolo M. Passoni
    Matthew Meissner
    Yair Lotan
    World Journal of Urology, 2017, 35 : 105 - 111
  • [39] Re: Anti-Inflammatory Use May Not Negatively Impact Oncologic Outcomes following Intravesical BCG for High-Grade Non-Muscle-Invasive Bladder Cancer
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2017, 198 (05): : 978 - 978